rb 6145 has been researched along with combretastatin a-4 disodium phosphate in 1 studies
| Studies (rb 6145) | Trials (rb 6145) | Recent Studies (post-2010) (rb 6145) | Studies (combretastatin a-4 disodium phosphate) | Trials (combretastatin a-4 disodium phosphate) | Recent Studies (post-2010) (combretastatin a-4 disodium phosphate) |
|---|---|---|---|---|---|
| 38 | 0 | 2 | 43 | 0 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaplin, DJ; Davis, P; Devkota, L; Gerberich, JL; Hamel, E; Kuch, B; MacDonough, MT; Mason, RP; Mondal, D; Pinney, KG; Ramirez, AJ; Shi, Z; Strecker, TE; Trawick, ML; Wang, Y; Winn, BA | 1 |
1 other study(ies) available for rb 6145 and combretastatin a-4 disodium phosphate
| Article | Year |
|---|---|
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Hypoxia; Colchicine; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; NADPH-Ferrihemoprotein Reductase; Prodrugs; Stilbenes; Tubulin | 2020 |